Table 2.
Clinical characteristic¶ | TBa | Non–TB | Total screenedb | P-valuec |
---|---|---|---|---|
# of subjects | 13 | 427 | 440 | |
TB contact | 2 (15.4) | 106 (24.8) | 108 (24.6) | 0.413 |
Gender (females) | 8 (61.5) | 322 (75.4) | 330 (75.0) | 0.277 |
Previous TB | 2 (15.4) | 84 (19.7) | 86 (19.6) | 0.693 |
Positive smear | 2 (15.4) | 0 (0.0) | 2 (0.5) | |
Positive culture | 1 (7.7) | 0 (0.0) | 1 (0.2) | |
Any TB symptom | 6 (46.2) | 199 (46.6) | 205 (46.6) | 0.974 |
1–2 symptoms | 3 (23.1) | 138 (14.5) | 141 (32.1) | |
≥3 symptoms | 3 (23.1) | 61 (32.1) | 64 (14.6) | |
Cough > 2 weeks | 3 (23.1) | 55 (12.9) | 58 (13.2) | 0.324 |
Fever | 3 (23.1) | 37 (8.7) | 40 (9.1) | 0.126 |
Weight loss | 3 (23.1) | 71 (16.6) | 74 (16.8) | 0.557 |
Fatigue | 2 (15.4) | 135 (31.6) | 137 (31.1) | 0.185 |
Blood–stained sputum | 2 (15.4) | 4 (0.9) | 6 (1.4) | 0.008 |
Chest pain | 2 (15.4) | 45 (10.5) | 47 (10.7) | 0.598 |
Night sweats | 2 (15.4) | 70 (16.4) | 72 (16.4) | 0.922 |
Hypertension (n = 435) | 7 (53.8) | 255 (60.4) | 262 (60.2) | 0.636 |
Triglycerides (mg/dL) (n = 436) | 1.4 [1.3–2.0] | 1.3 [1.0–1.7] | 1.3 [1.0–1.8] | 0.108 |
BMIa,d (kg/m2) (n = 434) | 28.6 [25.11–45.08] | 32.8 [28.60–38.64] | 32.7 [28.37–38.73] | 0.895 |
≤18.5 (underweight) | 0 (0.0) | 3 (0.7) | 3 (0.7) | 0.314 |
18.5–24.9 (normal) | 3 (23.1) | 48 (11.4) | 51 (11.8) | |
25–29.9 (overweight) | 4 (30.8) | 94 (22.3) | 98 (22.6) | |
≥30 (obese) | 6 (46.2) | 276 (65.6) | 282 (65.0) | |
Diabetes control (n = 435) | ||||
Poorly controlled | 12 (92.3) | 336 (79.6) | 348 (80.0) | 0.212 |
HbA1ca,d,e (n = 435) | 9.5 [8.20–9.90] | 9.1 [7.30–11.00] | 9.2 [7.30–11.00] | 0.897 |
4.8–7.7% (6.7 ± 0.69) | 2 (15.4) | 143 (33.9) | 145 (33.3) | 0.212 |
7.8–10.3% (9.1 ± 0.80) | 9 (69.2) | 138 (32.7) | 147 (33.8) | |
10.4–18.4% (12.0 ± 1.33) | 2 (15.4) | 141 (33.4) | 143 (32.9) | |
Fasting plasma glucosed,e (mmol/L) (n = 434) | 8.2 [6.3–10.4] | 8.2 [6.1–11.7] | 8.2 [6.1–11.6] | 0.807 |
2.7–6.8 (5.4 ± 0.97) | 5 (38.5) | 145 (34.4) | 150 (34.6) | 0.821 |
6.9–10.4 (8.5 ± 1.06) | 5 (38.5) | 136 (32.3) | 141 (32.5) | |
10.5–23.5 (13.8 ± 2.66) | 3 (23.1) | 140 (33.3) | 143 (33.0) |
Unless otherwise noted data presented as n, n (%).
BMI: body mass index; HbA1c: glycated hemoglobin; TB: tuberculosis.
Sample size indicated where data is missing.
Logistic regression analysis.
Data presented in median (interquartile range).
Categories presented in tertiles (mean ± standard deviation).